Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.

J Assist Reprod Genet. 2013 Jan;30(1):49-62. doi: 10.1007/s10815-012-9890-z. Epub 2012 Dec 5.

2.

Hypoandrogenism in association with diminished functional ovarian reserve.

Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.

Hum Reprod. 2013 Apr;28(4):1084-91. doi: 10.1093/humrep/det033. Epub 2013 Feb 20.

3.

The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation.

Weghofer A, Kim A, Barad DH, Gleicher N.

Hum Reprod. 2012 Nov;27(11):3287-93. doi: 10.1093/humrep/des265. Epub 2012 Jul 18.

4.

Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?

Kara M, Aydin T, Aran T, Turktekin N, Ozdemir B.

Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:63-5. doi: 10.1016/j.ejogrb.2013.11.008. Epub 2013 Nov 18.

PMID:
24331115
5.

Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.

Yilmaz N, Uygur D, Inal H, Gorkem U, Cicek N, Mollamahmutoglu L.

Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):257-60. doi: 10.1016/j.ejogrb.2013.04.003. Epub 2013 May 9.

PMID:
23664458
6.

Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte.

Gleicher N, Kim A, Weghofer A, Barad DH.

J Clin Endocrinol Metab. 2012 Mar;97(3):995-1004. doi: 10.1210/jc.2011-2403. Epub 2011 Dec 14.

PMID:
22170712
7.

A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.

Yeung TW, Chai J, Li RH, Lee VC, Ho PC, Ng EH.

Fertil Steril. 2014 Jul;102(1):108-115.e1. doi: 10.1016/j.fertnstert.2014.03.044. Epub 2014 May 3.

PMID:
24796766
8.

Clinical relevance of combined FSH and AMH observations in infertile women.

Gleicher N, Kim A, Kushnir V, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.

J Clin Endocrinol Metab. 2013 May;98(5):2136-45. doi: 10.1210/jc.2013-1051. Epub 2013 Mar 26.

PMID:
23533225
9.

Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation.

Gleicher N, Weghofer A, Barad DH.

Reprod Biomed Online. 2010 Sep;21(3):360-5. doi: 10.1016/j.rbmo.2010.04.006. Epub 2010 Apr 18.

PMID:
20638339
10.

Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels.

Weissman A, Horowitz E, Ravhon A, Golan A, Levran D.

Gynecol Endocrinol. 2011 Dec;27(12):1014-7. doi: 10.3109/09513590.2011.569611. Epub 2011 Apr 18.

PMID:
21500990
11.

Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.

Keane KN, Hinchliffe PM, Namdar N, Conceicao JL, Newsholme P, Yovich JL.

Drug Des Devel Ther. 2015 Oct 9;9:5569-78. doi: 10.2147/DDDT.S92467. eCollection 2015.

12.

Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study.

Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH.

Reprod Biol Endocrinol. 2009 Oct 7;7:108. doi: 10.1186/1477-7827-7-108.

13.

A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.

Singh N, Zangmo R, Kumar S, Roy KK, Sharma JB, Malhotra N, Vanamail P.

Gynecol Endocrinol. 2013 Nov;29(11):989-92. doi: 10.3109/09513590.2013.824957. Epub 2013 Sep 4.

PMID:
24004296
14.

Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene.

Gleicher N, Kim A, Weghofer A, Barad DH.

Reprod Biol Endocrinol. 2012 Sep 10;10:77. doi: 10.1186/1477-7827-10-77.

15.

Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.

Vlahos N, Papalouka M, Triantafyllidou O, Vlachos A, Vakas P, Grimbizis G, Creatsas G, Zikopoulos K.

Reprod Biomed Online. 2015 Feb;30(2):191-6. doi: 10.1016/j.rbmo.2014.10.005. Epub 2014 Oct 27.

PMID:
25498594
16.

Effect of inter-cycle interval on oocyte production in humans in the presence of the weak androgen DHEA and follicle stimulating hormone: a case-control study.

Barad DH, Kushnir VA, Lee HJ, Lazzaroni E, Gleicher N.

Reprod Biol Endocrinol. 2014 Jul 21;12:68. doi: 10.1186/1477-7827-12-68.

17.

Predictive value of androgens and multivariate model for poor ovarian response.

Guo J, Zhang Q, Li Y, Huang J, Wang W, Huang L, Zhao X, Yang D.

Reprod Biomed Online. 2014 Jun;28(6):723-32. doi: 10.1016/j.rbmo.2014.02.009. Epub 2014 Mar 4.

PMID:
24745840
18.

High live birth rate in the subsequent IVF cycle after first-cycle poor response among women with mean age 35 and normal FSH.

Moolenaar LM, Mohiuddin S, Munro Davie M, Merrilees MA, Broekmans FJ, Mol BW, Johnson NP.

Reprod Biomed Online. 2013 Oct;27(4):362-6. doi: 10.1016/j.rbmo.2013.07.004. Epub 2013 Jul 18.

PMID:
23953583
19.

Effects of dehydroepiandrosterone on in vivo ovine follicular development.

Narkwichean A, Jayaprakasan K, Maalouf WE, Hernandez-Medrano JH, Pincott-Allen C, Campbell BK.

Hum Reprod. 2014 Jan;29(1):146-54. doi: 10.1093/humrep/det408. Epub 2013 Nov 20.

20.

Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis.

Narkwichean A, Maalouf W, Campbell BK, Jayaprakasan K.

Reprod Biol Endocrinol. 2013 May 16;11:44. doi: 10.1186/1477-7827-11-44. Review.

Items per page

Supplemental Content

Write to the Help Desk